Tower Research Capital (TRC)’s National Healthcare NHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $277K | Buy |
1,734
+1,422
| +456% | +$218K | 0.01% | 1368 |
|
|
2025
Q4 | $42.8K | Sell |
312
-524
| -63% | -$67.7K | ﹤0.01% | 2549 |
|
|
2025
Q3 | $102K | Sell |
836
-1,080
| -56% | -$117K | ﹤0.01% | 1978 |
|
|
2025
Q2 | $205K | Buy |
1,916
+1,425
| +290% | +$142K | 0.01% | 1750 |
|
|
2025
Q1 | $45.6K | Sell |
491
-4,920
| -91% | -$477K | ﹤0.01% | 2287 |
|
|
2024
Q4 | $582K | Buy |
5,411
+1,758
| +48% | +$214K | 0.01% | 955 |
|
|
2024
Q3 | $459K | Sell |
3,653
-801
| -18% | -$101K | 0.01% | 927 |
|
|
2024
Q2 | $483K | Buy |
4,454
+903
| +25% | +$88K | 0.01% | 1376 |
|
|
2024
Q1 | $336K | Sell |
3,551
-4,140
| -54% | -$392K | 0.01% | 1096 |
|
|
2023
Q4 | $711K | Buy |
7,691
+5,990
| +352% | +$459K | 0.01% | 1095 |
|
|
2023
Q3 | $109K | Sell |
1,701
-139
| -8% | -$8.9K | ﹤0.01% | 1923 |
|
|
2023
Q2 | $114K | Sell |
1,840
-876
| -32% | -$52K | ﹤0.01% | 1943 |
|
|
2023
Q1 | $158K | Sell |
2,716
-289
| -10% | -$16.6K | 0.01% | 1504 |
|
|
2022
Q4 | $179K | Buy |
3,005
+105
| +4% | +$6.37K | 0.01% | 1378 |
|
|
2022
Q3 | $183K | Buy |
2,900
+485
| +20% | +$33.7K | ﹤0.01% | 2019 |
|
|
2022
Q2 | $169K | Buy |
2,415
+238
| +11% | +$16.7K | ﹤0.01% | 1900 |
|
|
2022
Q1 | $153K | Sell |
2,177
-228
| -9% | -$15.3K | ﹤0.01% | 1933 |
|
|
2021
Q4 | $164K | Buy |
2,405
+242
| +11% | +$16.7K | ﹤0.01% | 1906 |
|
|
2021
Q3 | $151K | Sell |
2,163
-1,888
| -47% | -$137K | ﹤0.01% | 2067 |
|
|
2021
Q2 | $283K | Buy |
4,051
+1,483
| +58% | +$108K | 0.01% | 1646 |
|
|
2021
Q1 | $200K | Sell |
2,568
-4,170
| -62% | -$295K | ﹤0.01% | 2014 |
|
|
2020
Q4 | $447K | Sell |
6,738
-9,121
| -58% | -$601K | 0.01% | 1080 |
|
|
2020
Q3 | $988K | Buy |
15,859
+10,736
| +210% | +$672K | 0.01% | 1010 |
|
|
2020
Q2 | $325K | Buy |
5,123
+3,635
| +244% | +$244K | 0.01% | 1373 |
|
|
2020
Q1 | $107K | Buy |
1,488
+451
| +43% | +$35.7K | 0.01% | 967 |
|
|
2019
Q4 | $90K | Buy |
1,037
+271
| +35% | +$22.6K | 0.01% | 993 |
|
|
2019
Q3 | $63K | Buy |
766
+279
| +57% | +$23.1K | ﹤0.01% | 1631 |
|
|
2019
Q2 | $40K | Buy |
487
+315
| +183% | +$24.3K | ﹤0.01% | 1742 |
|
|
2019
Q1 | $13K | Sell |
172
-463
| -73% | -$36.7K | ﹤0.01% | 2532 |
|
|
2018
Q4 | $50K | Buy |
+635
| New | +$49.7K | ﹤0.01% | 1288 |
|
|
2018
Q3 | – | Sell |
-1,036
| Closed | -$73K | – | 4094 |
|
|
2018
Q2 | $73K | Buy |
1,036
+901
| +667% | +$59K | ﹤0.01% | 1630 |
|
|
2018
Q1 | $8K | Sell |
135
-268
| -67% | -$16.4K | ﹤0.01% | 2556 |
|
|
2017
Q4 | $25K | Buy |
403
+115
| +40% | +$7.34K | ﹤0.01% | 1887 |
|
|
2017
Q3 | $18K | Buy |
+288
| New | +$18.6K | ﹤0.01% | 2790 |
|
|
2017
Q2 | – | Sell |
-100
| Closed | -$7K | – | 3192 |
|
|
2017
Q1 | $7K | Sell |
100
-539
| -84% | -$39.9K | ﹤0.01% | 2014 |
|
|
2016
Q4 | $49K | Buy |
+639
| New | +$44.3K | 0.01% | 1444 |
|
|
2016
Q2 | – | Sell |
-31
| Closed | -$2K | – | 4787 |
|
|
2016
Q1 | $2K | Sell |
31
-1,088
| -97% | -$67.8K | ﹤0.01% | 3410 |
|
|
2015
Q4 | $69K | Buy |
1,119
+146
| +15% | +$9.46K | 0.01% | 423 |
|
|
2015
Q3 | $59K | Buy |
973
+953
| +4,765% | +$59.6K | 0.01% | 904 |
|
|
2015
Q2 | $1K | Sell |
20
-12
| -38% | -$762 | ﹤0.01% | 4033 |
|
|
2015
Q1 | $2K | Buy |
+32
| New | +$2.03K | ﹤0.01% | 3800 |
|
|
2014
Q4 | – | Sell |
-1,585
| Closed | -$88K | – | 4455 |
|
|
2014
Q3 | $88K | Buy |
+1,585
| New | +$89.5K | 0.01% | 1075 |
|
|
2014
Q2 | – | Sell |
-2,116
| Closed | -$118K | – | 4438 |
|
|
2014
Q1 | $118K | Buy |
+2,116
| New | +$111K | 0.02% | 628 |
|
|
2013
Q4 | – | Sell |
-140
| Closed | -$7K | – | 4779 |
|
|
2013
Q3 | $7K | Buy |
140
+56
| +67% | +$2.68K | ﹤0.01% | 3449 |
|
|
2013
Q2 | $4K | Buy |
+84
| New | +$3.92K | ﹤0.01% | 3098 |
|
Other funds holding NHC
MSIIA
VPM
VCM
MHS
Tower Research Capital (TRC)'s NHC Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its National Healthcare (NHC) stake by 456% in Q1 2026, buying an estimated $218K and bringing the position to 1,734 shares worth $277K. The position accounts for 0.01% of the portfolio, ranked #1368.
Tower Research Capital (TRC) first reported a position in NHC in Q2 2013 and has held it in 45 quarters since. The position peaked at $988K in Q3 2020. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.
- Tower Research Capital (TRC) held 1,734 shares of National Healthcare worth $277K as of Q1 2026.
- Tower Research Capital (TRC) bought 1,422 National Healthcare shares in Q1 2026, an estimated $218K.
- National Healthcare made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1368 holding.
- Tower Research Capital (TRC) first reported a position in National Healthcare in Q2 2013 and has held it in 45 quarters since.
- Tower Research Capital (TRC)'s National Healthcare position peaked at $988K in Q3 2020.
- 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.